A study of SGN BB228 in advanced melanoma and other solid tumors

Clinical Trial Grant

Duke Scholars

Principal Investigator April Kelly Scott Salama Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Seagen, Inc

Start Date

April 13, 2023

End Date

April 1, 2028

Administered By

Duke Cancer Institute

Awarded By

Seagen, Inc

Start Date

April 13, 2023

End Date

April 1, 2028